A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
Therapeutic drug monitoring (TDM) is a useful strategy to optimize biologic medications for inflammatory bowel disease not responsive to standard dosing regimens. TDM is cost effective for anti-tumor necrosis factor agents in the setting of loss of response (reactive TDM). Optimizing drug dosing whe...
Guardado en:
Autor principal: | Byron P. Vaughn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c687800ac5f44d32a4a67e75fb227378 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
por: Rawla P, et al.
Publicado: (2018) -
Selective biologics for ulcerative colitis and Crohn's disease – clinical utility of vedolizumab
por: Petkau JM, et al.
Publicado: (2016) -
Rol de infliximab en enfermedad inflamatoria intestinal: Experiencia local
por: Simian,Daniela, et al.
Publicado: (2013) -
Utilidad de la monitorización terapéutica de infliximab en el manejo de la enfermedad inflamatoria intestinal
por: Quera,Rodrigo, et al.
Publicado: (2018) -
Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?
por: Javier P. Gisbert, et al.
Publicado: (2021)